
SR9243
CAS No. 1613028-81-1
SR9243( SR9243 | SR-9243 | SR 9243. )
Catalog No. M12335 CAS No. 1613028-81-1
SR9243 is a LXR inverse agonist that induces LXR-corepressor interaction.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 29 | In Stock |
![]() ![]() |
5MG | 46 | In Stock |
![]() ![]() |
10MG | 65 | In Stock |
![]() ![]() |
25MG | 113 | In Stock |
![]() ![]() |
50MG | 177 | In Stock |
![]() ![]() |
100MG | 327 | In Stock |
![]() ![]() |
200MG | 518 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameSR9243
-
NoteResearch use only, not for human use.
-
Brief DescriptionSR9243 is a LXR inverse agonist that induces LXR-corepressor interaction.
-
DescriptionSR9243 is a LXR inverse agonist that induces LXR-corepressor interaction; shows anticancer activity and selectively targets the warburg effect and lipogenesis.
-
In Vitro——
-
In Vivo——
-
SynonymsSR9243 | SR-9243 | SR 9243.
-
PathwayNuclear Receptor/Transcription Factor
-
TargetLXR
-
RecptorLXR
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1613028-81-1
-
Formula Weight626.62
-
Molecular FormulaC31H32BrNO4S2
-
Purity>98% (HPLC)
-
SolubilityDMF: 98 mg/mL warming (156.39 mM)
-
SMILESO=S(C1=C(C)C=C(C)C=C1C)(N(CCC2=CC=CC(Br)=C2)CC3=CC=C(C4=CC=CC(S(=O)(C)=O)=C4)C=C3)=O
-
Chemical NameN-(3-bromophenethyl)-2,4,6-trimethyl-N-((3'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)methyl)benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Flaveny CA, et al. Y Cell. 2015 Jun 24. pii: S1535-6108(15)00183-X.
molnova catalog



related products
-
GW3965
A potent, selective, orally active LXR agonist that recruits the steroid receptor coactivator 1 to human LXRα in a cell-free ligand-sensing assay with an EC50 of 125 nM.
-
BMS-779788
A potent, highly selective partial LXR agonist with Ki of 14 nM for LXRβ.
-
LXR-623
A clinically viable, highly brain-penetrant LXRα-partial/LXRβ-full agonist with binding Ki of 33 nM/248 nM.